CN111529637A - 一种治疗脑供血不足、脑血栓、脑梗塞、dic、提高免疫力的药物 - Google Patents
一种治疗脑供血不足、脑血栓、脑梗塞、dic、提高免疫力的药物 Download PDFInfo
- Publication number
- CN111529637A CN111529637A CN202010382507.3A CN202010382507A CN111529637A CN 111529637 A CN111529637 A CN 111529637A CN 202010382507 A CN202010382507 A CN 202010382507A CN 111529637 A CN111529637 A CN 111529637A
- Authority
- CN
- China
- Prior art keywords
- cerebral
- stirring
- decocting
- equipment
- dic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Insects & Arthropods (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Husbandry (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
Abstract
本发明提出了一种治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物,包括以下组方配伍重量比:人参2‑30g、北冬虫夏草2‑25g、茯岺5‑50g、鸡内金5‑50g、当归5‑50g、山药5‑25g、杜仲3‑44g、芦根5‑50g、栀子5‑50g、枸杞子5‑35g、甘草5‑30g、薏苡仁5‑50g、玉米须10‑50g、蚕蛹5‑50g、鹿鞭5‑50g、牡蛎5‑50g、白茅根5‑50g和肉桂5‑50g。本发明对脑供血不足、脑血栓、脑梗塞和DIC均具有良好的治疗效果,且还可以具有提高免疫力的功能。
Description
技术领域
本发明涉及药物制备技术领域,尤其涉及一种治疗脑供血不足、 脑血栓、脑梗塞、DIC、提高免疫力的药物。
背景技术
脑供血不足、脑血栓、脑梗塞和DIC是我们生活中比较常见的病 症,其中DIC是弥散性血管内凝血的简称,DIC是一类获得性的疾病, 发生在许多疾病的病理过程中。由于小血管发生凝血,形成广泛的微 血栓,大量的凝血因子被消耗,并继发激活纤维蛋白溶解,因而引起 严重的广泛的全身性出血,本病在临床上可有出血、休克、器官损害、 溶血等一系列的主要表现,病势凶险,死亡率高。在90%的DIC尸 解的病例中,可发现微血管内有微血栓形成及纤维蛋白沉着,以肺、 肾、胃肠道、肾上腺等器官中较多见,在DIC中发病机理最主要的变 化是由于凝血酶及纤溶酶两方面引起的后果,两者的作用在体内产生 了许多凝血和纤溶活性的物质。两者的作用又可因不同的病因,病情 的缓急轻重而异,也可在疾病的不同时相中产生不同的变化,要经过 一系列的化验检查加以发现,在凝血酶的作用方面,首先是使纤维蛋 白原分解出蛋白肽A,形成纤维蛋白单体,单体相互聚合成纤维蛋白, 并在因子VIII的交联作用下形成血栓,但纤维蛋白(原)也可与纤维 蛋白裂解产物(FDP)形成可溶性复合物,凝血酶还可激活因子V、VIII、 XIII、蛋白C系统和血小板,刺激多种活性介质物质的产生如血小板 激活因子(PAF)、前列环素、VW因子等,凝血酶还可通过血管内皮细胞影响纤溶系统,因此体内凝血酶活性的改变就会引起体内有关生化 凝血活性物质的各种变化;另外脑供血不足、脑血栓和脑梗塞是同一 个病的不同阶段,当脑供血不足、脑血栓、脑梗塞和DIC出现在人们 身上时,会造成人们的免疫力下降,目前还没有一种药物可以同时治 疗脑供血不足、脑血栓、脑梗塞、DIC和免疫力低,因此我们提出了 一种治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物。
发明内容
为了解决现有技术所存在的问题,本发明提出的一种治疗脑供血 不足、脑血栓、脑梗塞、DIC、提高免疫力的药物。
为了实现上述目的,本发明采用了如下技术方案:
一种治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药 物,包括以下组方配伍重量比:人参2-30g、北冬虫夏草2-25g、茯 岺5-50g、鸡内金5-50g、当归5-50g、山药5-25g、杜仲3-44g、芦 根5-50g、栀子5-50g、枸杞子5-35g、甘草5-30g、薏苡仁5-50g、 玉米须10-50g、蚕蛹5-50g、鹿鞭5-50g、牡蛎5-50g、白茅根5-50g 和肉桂5-50g;
其制备方法如下:
S1:将所需要的原料人参2-30g、北冬虫夏草2-25g、茯岺5-50g、 鸡内金5-50g、当归5-50g、山药5-25g、杜仲3-44g、芦根5-50g、 栀子5-50g、枸杞子5-35g、甘草5-30g、薏苡仁5-50g、玉米须10-50g、 蚕蛹5-50g、鹿鞭5-50g、牡蛎5-50g、白茅根5-50g和肉桂5-50g 准备好;
S2:将S1中所准备的原料依次利用超声波粉碎设备进行粉碎处 理,得到块状的原料;
S3:将S2中块状的原料利用高速研磨设备进行研磨处理,得到 粉状的原料;
S4:将S3中的各种粉状的原料利用搅拌设备进行搅拌处理;
S5:S4中经过搅拌处理的粉状原料放到煎煮设备上,并在煎煮 设备中加入10-14倍重量的无菌纯净水,煎煮设备对其内部的粉状原 料和无菌纯净水进行煎煮3-5h,且煎煮的过程中需要利用搅拌设备 进行搅拌;
S6:S5中所述的煎煮设备的煎煮完成后,将其内部的溶液利用 过滤装置进行过滤,得到一级滤液和一级滤渣;
S7:将S6中所述的一级滤渣放到煎煮设备上,并在煎煮设备中 加入10-14倍重量的无菌纯净水,煎煮设备对其内部的粉状原料和无 菌纯净水进行煎煮3-5h,且煎煮的过程中需要利用搅拌设备进行搅 拌;
S8:S7中所述的煎煮设备的煎煮完成后,将其内部的溶液利用 过滤装置进行过滤,得到二级滤液和二级滤渣;
S9:将S8中所述的二级滤液和S6中所述的一级滤液进行合并, 然后利用浓缩设备进行浓缩,得到块状的结晶体;
S10:S9中所述的块状的结晶体利用烘干设备进行干燥处理,然 后在无菌的环境下进行研磨操作,得到粉状的结晶体;
S11:S10中所述的粉状的结晶体在无菌的环境下进行包装操作, 得到治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物。
优选的,所述S4中,搅拌设备的内部温度设置为30-40℃,且 搅拌设备的内部安装有用于杀菌的紫外线杀菌设备。
优选的,所述S5和S7中,搅拌设备为带搅拌浆的搅拌棒,并设 置在煎煮设备的内部。
优选的,所述S6和S8中,过滤装置为18-20目的筛网。
与现有技术相比,本发明对脑供血不足、脑血栓、脑梗塞和DIC 均具有良好的治疗效果,且还可以具有提高免疫力的功能。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清 楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例, 而不是全部的实施例。
本实施例中提出了一种治疗脑供血不足、脑血栓、脑梗塞、DIC、 提高免疫力的药物,包括以下组方配伍重量比:人参2-30g、北冬虫 夏草2-25g、茯岺5-50g、鸡内金5-50g、当归5-50g、山药5-25g、 杜仲3-44g、芦根5-50g、栀子5-50g、枸杞子5-35g、甘草5-30g、 薏苡仁5-50g、玉米须10-50g、蚕蛹5-50g、鹿鞭5-50g、牡蛎5-50g、 白茅根5-50g和肉桂5-50g;
其制备方法如下:
S1:将所需要的原料人参2-30g、北冬虫夏草2-25g、茯岺5-50g、 鸡内金5-50g、当归5-50g、山药5-25g、杜仲3-44g、芦根5-50g、 栀子5-50g、枸杞子5-35g、甘草5-30g、薏苡仁5-50g、玉米须10-50g、 蚕蛹5-50g、鹿鞭5-50g、牡蛎5-50g、白茅根5-50g和肉桂5-50g 准备好;
S2:将S1中所准备的原料依次利用超声波粉碎设备进行粉碎处 理,得到块状的原料;
S3:将S2中块状的原料利用高速研磨设备进行研磨处理,得到 粉状的原料;
S4:将S3中的各种粉状的原料利用搅拌设备进行搅拌处理,搅 拌设备的内部温度设置为30℃,且搅拌设备的内部安装有用于杀菌 的紫外线杀菌设备;
S5:S4中经过搅拌处理的粉状原料放到煎煮设备上,并在煎煮 设备中加入10倍重量的无菌纯净水,煎煮设备对其内部的粉状原料 和无菌纯净水进行煎煮3h,且煎煮的过程中需要利用搅拌设备进行 搅拌,搅拌设备为带搅拌浆的搅拌棒,并设置在煎煮设备的内部;
S6:S5中所述的煎煮设备的煎煮完成后,将其内部的溶液利用 过滤装置进行过滤,过滤装置为18-20目的筛网,得到一级滤液和一 级滤渣;
S7:将S6中所述的一级滤渣放到煎煮设备上,并在煎煮设备中 加入10倍重量的无菌纯净水,煎煮设备对其内部的粉状原料和无菌 纯净水进行煎煮3h,且煎煮的过程中需要利用搅拌设备进行搅拌, 搅拌设备为带搅拌浆的搅拌棒,并设置在煎煮设备的内部;
S8:S7中所述的煎煮设备的煎煮完成后,将其内部的溶液利用 过滤装置进行过滤,过滤装置为18-20目的筛网,得到二级滤液和二 级滤渣;
S9:将S8中所述的二级滤液和S6中所述的一级滤液进行合并, 然后利用浓缩设备进行浓缩,得到块状的结晶体;
S10:S9中所述的块状的结晶体利用烘干设备进行干燥处理,然 后在无菌的环境下进行研磨操作,得到粉状的结晶体;
S11:S10中所述的粉状的结晶体在无菌的环境下进行包装操作, 得到治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物。
临床实践与效果验证
实施病例一:
李先生,62岁,5年前出现头晕、头昏反复发作,当时CT检查提 示“脑梗塞”,经治疗后好转,5年来,上述症状反复发作,平时自 行口服“血塞通”等药物治疗,生活尚能自理。2015年10月,在朋友 的介绍下开始服用本发明药,每天2次,3个月后复查CT,发现梗塞 部位已经缩小了80%,嘱其再服3个月检查,CT检查已经全部通畅了, 嘱其注意饮食、运动和生活方式的科学化,每年2-3次随访至今,各 种脑梗症状均未出现。
实施病例二:
周X,女,73岁,4年前出现走路不稳、头晕、头昏反复发作, 当时CT检查提示“脑梗塞”,经治疗后好转,4年来,上述症状反 复发作,平时自行口服“阿司匹林”“血塞通”等药物治疗,生活尚 能自理。2015年7月,开始服用本发明药,每天2次,3个月后复查CT, 发现梗塞部位已经缩小了75%,嘱其再服3-4个月再检查,CT检查已 经全部通畅了,嘱其注意饮食、运动和生活方式的科学化,每年2-3 次随访至今,各种脑梗症状均未出现。
实施病例三:
杨XX,女,66岁,6年前出现走路不稳、头晕、头昏反复发作, 当时CT检查提示“脑梗塞”,经治疗后好转,6年来,上述症状反 复发作,平时自行口服“阿司匹林”“血塞通”等药物治疗,病情严 重时去社区医院输液治疗,生活尚能自理。2013年9月,开始服用本 发明药,每天2次,3个月后复查CT,发现梗塞部位已经缩小了85%, 嘱其再服3个月再检查,CT检查已经全部通畅了,嘱其注意饮食、运 动和生活方式的科学化,每年2-3次随访至今,各种脑梗症状均未出 现。
2013年-2019我们对490例确诊的脑梗患者病例进行临床试验, 按比例分为新药组(A组)和对照组(B组),对照组按常规治疗,用 药组全部取消了常规治疗的所有药物,只使用“脈通(本发明)”进 行治疗。临床试验表明:使用了“脈通(本发明)”的脑梗患者服药后分为如下几种情况。
另附:A.B两组分别用药的效果统计表:
表一:“脈通(本发明)”组(A组)与“尿激酶+胞二磷酸胆碱” 组(B组)的疗效对比表
由上述数据可知,本发明制得的治疗脑供血不足、脑血栓、脑梗 塞、DIC、提高免疫力的药物,具有补肝益肾、补肺助脾、活血祛瘀、 益气通络、激活受损的脑细胞、改善受损的神经细胞、重建或修复微 循环系统、对脑供血不足、脑血栓、脑梗塞和DIC均具有良好的治疗 效果,且还可以具有提高免疫力的功能。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范 围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技 术范围内,根据本发明的技术方案及其发明构思加以等同替换或改 变,都应涵盖在本发明的保护范围之内。
Claims (4)
1.一种治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物,其特征在于,包括以下组方配伍重量比:人参2-30g、北冬虫夏草2-25g、茯岺5-50g、鸡内金5-50g、当归5-50g、山药5-25g、杜仲3-44g、芦根5-50g、栀子5-50g、枸杞子5-35g、甘草5-30g、薏苡仁5-50g、玉米须10-50g、蚕蛹5-50g、鹿鞭5-50g、牡蛎5-50g、白茅根5-50g和肉桂5-50g。其制备方法如下:
S1:将所需要的原料人参2-30g、北冬虫夏草2-25g、茯岺5-50g、鸡内金5-50g、当归5-50g、山药5-25g、杜仲3-44g、芦根5-50g、栀子5-50g、枸杞子5-35g、甘草5-30g、薏苡仁5-50g、玉米须10-50g、蚕蛹5-50g、鹿鞭5-50g、牡蛎5-50g、白茅根5-50g和肉桂5-50g。准备好;
S2:将S1中所准备的原料依次利用超声波粉碎设备进行粉碎处理,得到块状的原料;
S3:将S2中块状的原料利用高速研磨设备进行研磨处理,得到粉状的原料;
S4:将S3中的各种粉状的原料利用搅拌设备进行搅拌处理;
S5:将S4中将经过搅拌处理的粉状原料放到煎煮设备上,并在煎煮设备中加入10-14倍重量的无菌纯净水,煎煮设备对其内部的粉状原料和无菌纯净水进行煎煮3-5h,且煎煮的过程中需要利用搅拌设备进行搅拌;
S6:将S5中所述的煎煮设备的煎煮完成后,将其内部的溶液利用过滤装置进行过滤,得到一级滤液和一级滤渣;
S7:将S6中所述的一级滤渣放到煎煮设备上,并在煎煮设备中加入10-14倍重量的无菌纯净水,煎煮设备对其内部的粉状原料和无菌纯净水进行煎煮3-5h,且煎煮的过程中需要利用搅拌设备进行搅拌;
S8:S7中所述的煎煮设备的煎煮完成后,将其内部的溶液利用过滤装置进行过滤,得到二级滤液和二级滤渣;
S9:将S8中所述的二级滤液和S6中所述的一级滤液进行合并,然后利用浓缩设备进行浓缩,得到块状的结晶体;
S10:将S9中所述的块状的结晶体利用烘干设备进行干燥处理,然后在无菌的环境下进行研磨操作,得到粉状的结晶体;
S11:S10中所述的粉状的结晶体在无菌的环境下进行包装操作,得到治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物。
2.根据权利要求1所述的一种治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物,其特征在于,所述S4中,搅拌设备的内部温度设置为30-40℃,且搅拌设备的内部安装有用于杀菌的紫外线杀菌设备。
3.根据权利要求1所述的一种治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物,其特征在于,所述S5和S7中,搅拌设备为带搅拌浆的搅拌棒,并设置在煎煮设备的内部。
4.根据权利要求1所述的一种治疗脑供血不足、脑血栓、脑梗塞、DIC、提高免疫力的药物,其特征在于,所述S6和S8中,过滤装置为18-20目的筛网。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010382507.3A CN111529637A (zh) | 2020-05-08 | 2020-05-08 | 一种治疗脑供血不足、脑血栓、脑梗塞、dic、提高免疫力的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010382507.3A CN111529637A (zh) | 2020-05-08 | 2020-05-08 | 一种治疗脑供血不足、脑血栓、脑梗塞、dic、提高免疫力的药物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111529637A true CN111529637A (zh) | 2020-08-14 |
Family
ID=71970721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010382507.3A Pending CN111529637A (zh) | 2020-05-08 | 2020-05-08 | 一种治疗脑供血不足、脑血栓、脑梗塞、dic、提高免疫力的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111529637A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111529653A (zh) * | 2020-05-13 | 2020-08-14 | 梅连武 | 一种治疗脑萎缩、阿尔茨海默症、记忆力减退、癫病的药物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111437375A (zh) * | 2020-05-13 | 2020-07-24 | 中科医药(深圳)有限公司 | 一种治疗哮喘的药物 |
CN111529653A (zh) * | 2020-05-13 | 2020-08-14 | 梅连武 | 一种治疗脑萎缩、阿尔茨海默症、记忆力减退、癫病的药物 |
-
2020
- 2020-05-08 CN CN202010382507.3A patent/CN111529637A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111437375A (zh) * | 2020-05-13 | 2020-07-24 | 中科医药(深圳)有限公司 | 一种治疗哮喘的药物 |
CN111529653A (zh) * | 2020-05-13 | 2020-08-14 | 梅连武 | 一种治疗脑萎缩、阿尔茨海默症、记忆力减退、癫病的药物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111529653A (zh) * | 2020-05-13 | 2020-08-14 | 梅连武 | 一种治疗脑萎缩、阿尔茨海默症、记忆力减退、癫病的药物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111529637A (zh) | 一种治疗脑供血不足、脑血栓、脑梗塞、dic、提高免疫力的药物 | |
CN106727625A (zh) | 单宁酸在抗血栓药物中的应用 | |
Kolmer et al. | A study of the histologic changes produced experimentally in rabbits by arsphenamin | |
CN109248177B (zh) | 鳄鱼甲有效组分的制备及其抗氧化、抗肝纤维化的应用 | |
Glass | Osteoplastic flap method in the treatment of subdural abscess | |
Aggeler et al. | Studies on the coagulation defect in a case of thrombocytopenic purpura complicated by thrombosis | |
Denzer et al. | Acute lupus erythematosus disseminatus | |
CN101987112A (zh) | 一种治疗心脑血管病的药物组合物及其制备方法 | |
Griffith et al. | PERSISTENT COMPLETE HEART BLOCK IN DIPHTHERITIC MYOCARDITIS: REPORT OF A CASE | |
CN100534458C (zh) | 一种治疗中风的药物及其制备方法 | |
CN100427106C (zh) | 一种用于治疗脑血管疾病的中药制剂及制备方法 | |
CN105456554B (zh) | 一种中药组合物在制备治疗视网膜静脉阻塞药物中的应用 | |
CN104161799B (zh) | 一种复方丹参提取物及其制备方法 | |
CN110585210B (zh) | 三棱素a在制备抗缺血性脑卒中的药物方面的应用 | |
DEL SOLAR et al. | Fatal poisoning from potassium thiocyanate used in treatment of hypertension: report of a case and review of the literature | |
CN106074366A (zh) | 治疗脑外伤及脑手术后意识障碍的注射液及其制备方法 | |
JP2023518007A (ja) | イカリチンの医薬使用 | |
CN100381125C (zh) | 一种治疗心脑血管病的药物组合物 | |
CN101919812B (zh) | 阿魏酸哌嗪的注射剂及其制备方法 | |
CN1562057A (zh) | 一种治疗心脑血管病的药物组合物 | |
CN117659129A (zh) | 一种黄精多肽及其制备方法和用途 | |
CN1121228C (zh) | 治疗心脑血管和高血压病的药及其制造方法 | |
Wang et al. | The mechanism of carthamin yellow injection promote acute myocardial infarction infarct border zone angiogenesis | |
CN1907320B (zh) | 中药组合物及由其制备中药的方法和用途 | |
CN108939057A (zh) | 一种治疗血栓的注射液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200814 |